CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- 4 Open-market buy Director bought 21,940 shares at $5.49 ($120,451)
- 4 Open-market buy Chief Legal Officer bought 5,000 shares at $5.53 ($27,650)
- 4 Open-market buy President & CEO bought 30,000 shares at $5.55 ($166,500)
- 4 Open-market buy Chief Commercial Officer bought 30,000 shares at $5.47 ($164,100)
- 4 Shares withheld for taxes Chief R&D Officer gave up 7,525 shares (to pay taxes)
- 4 Grant or award Director acquired 999 shares (grant or award)
- 4 Grant or award Director acquired 999 shares (grant or award)
- 4 Gift President & CEO gave 20,000 shares (gift)
- 4 Shares withheld for taxes Chief R&D Officer gave up 5,580 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 14,089 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,482 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,482 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 2,482 shares (to pay taxes)
- 4 Shares withheld for taxes Chief R&D Officer gave up 3,031 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 13,592 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 5,840 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,475 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 4,015 shares (to pay taxes)
- 4 Grant or award Director acquired 956 shares (grant or award)
- 4 Grant or award Director acquired 956 shares (grant or award)
Page 6 of 49 · 965 filings